This study documents how governance structures and institutional capacity influenced Ghana’s COVID-19 mass vaccination programme, launched in March 2021 with a stated target of vaccinating 20 million people by the end of 2022. Stakeholders identified multiple governance-related barriers to implementation: concerns about procurement transparency, gaps in public communication, high dependence on donor-supplied vaccines and funding, and operational constraints such as weaknesses in data systems and logistics. These issues affected the ability of implementers to plan, track, and deliver vaccines consistently across settings.
Respondents highlighted that transparency in procurement processes and clearer communication strategies were essential to public trust and smoother operations. Operational limitations—specifically in vaccine storage, distribution logistics, and data collection systems—were described as practical bottlenecks that reduced programme efficiency. The study presents these governance and capacity problems as central to understanding why rollout dynamics did not rest solely on clinical or epidemiological considerations but were tightly linked to institutional readiness and process integrity.
The thematic analysis revealed that the political economy surrounding procurement and distribution shaped decision-making. Leadership politics and bureaucratic dynamics influenced prioritisation and resource allocation; fiscal constraints limited the ability to secure and sustain vaccine supplies; and donor priorities and interest-group influence affected which vaccines were procured and how they were distributed.
Interviewees framed donor dependence as a double-edged reality: it enabled immediate access to vaccines and resources but also introduced external priorities that could conflict with national strategic objectives. Political incentives and inter-institutional interactions were reported to affect transparency, timing, and equity in distribution. These political factors operated alongside technical logistics, meaning that shifts in political will, funding availability, or stakeholder influence could substantially alter implementation trajectories.
Stakeholders offered a set of lessons and priorities to improve preparedness for future pandemics. Key recommendations included:
The authors emphasise that sustainable financing mechanisms and strategic institutional investments are critical if immunisation programmes are to be resilient in resource-constrained settings.
The research used a qualitative, exploratory, descriptive approach conducted between June and September 2021. Fourteen stakeholders were purposively selected as key informants; they represented the Ministry of Health, the Ghana Health Service, academia, political leadership, and professional associations. Interviews explored stakeholders’ perspectives on implementation challenges, political dynamics, and lessons for future pandemics.
Data analysis followed Braun and Clarke’s thematic analysis method. Interpretation was guided by the Health Policy Triangle and Campos and Reich’s policy implementation framework, linking empirical themes to established health policy theory. The report focuses on stakeholder perceptions rather than quantitative measures of programme coverage or clinical outcomes.
Ethical approval for the study was granted by the Dodowa Health Research Centre Institutional Review Board (DHRCIRB/051/05/21). All participants provided written consent, and confidentiality protections were implemented. The authors declared no competing interests.
Interview transcripts and qualitative data are not publicly available owing to ethical and legal restrictions and the risk of deductive disclosure given participants’ roles and the sensitive policy context. De-identified data may be made available to qualified researchers upon reasonable request, subject to approval by the Dodowa Health Research Centre IRB; requests should be directed to the IRB and copied to the corresponding author as specified in the report.
The study presents Ghana’s COVID-19 vaccine rollout as the product of intertwined technical, logistical, and political processes. Findings stress that improving vaccine programme implementation in similar contexts requires attention to governance transparency, communication, financing, local manufacturing capacity, and intersectoral coordination. The authors frame these institutional and governance dimensions as essential not only for the success of immunisation campaigns but for broader health system resilience in the face of future global health emergencies.